Aerovate Therapeutics
AVTE
#9019
Rank
S$0.10 B
Marketcap
$3.59
Share price
1.92%
Change (1 day)
-81.52%
Change (1 year)

Aerovate Therapeutics (AVTE) - Total liabilities

Total liabilities on the balance sheet as of June 2024 : S$23.31 Million

According to Aerovate Therapeutics's latest financial reports the company's total liabilities are S$23.31 Million. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Aerovate Therapeutics - Total liabilities on balance sheet (from 2020 to 2024)

Total liabilities by year

Year Total liabilities Change
2022-12-31S$11.47 M188.16%
2021-12-31S$3.98 M-83.34%
2020-12-31S$23.89 M147.6%
2019-12-31S$9.64 M